These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21456392)

  • 21. Adjuvant therapy for pancreatic cancer: to treat or not to treat?
    Berlin JD
    Oncology (Williston Park); 2007 May; 21(6):712-8; discussion 720, 725-6, 730. PubMed ID: 17564327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy for localized pancreatic cancer: too little or too long?
    White RR; Evans DB
    Ann Surg Oncol; 2014 May; 21(5):1508-9. PubMed ID: 24452411
    [No Abstract]   [Full Text] [Related]  

  • 23. [Postoperative adjuvant treatment for pancreatic cancer: present status and future perspective].
    Uesaka K; Kanemoto H; Sugiura T; Mizuno T; Okamura Y; Kinugasa Y; Bando E; Terashima M
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1403-5. PubMed ID: 21918335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
    Zhu AX; Clark JW; Willett CG
    Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
    Meszoely IM; Wang H; Hoffman JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of neoadjuvant chemotherapy for resectable pancreatic carcinoma].
    Motoi F; Kawaguchi K; Aoki T; Kudo K; Yabuuchi S; Fukase K; Mizuma M; Sakata N; Otsutomo S; Morikawa T; Hayashi H; Nakagawa K; Okada T; Yoshida H; Naitoh T; Katayose Y; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1632-6. PubMed ID: 24393872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients.
    Olecki EJ; Gusani NJ
    Ann Surg Oncol; 2021 Jun; 28(6):3123. PubMed ID: 33616769
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined-modality treatment for operable pancreatic adenocarcinoma.
    Pisters PW; Wolff RA; Crane CH; Evans DB
    Oncology (Williston Park); 2005 Mar; 19(3):393-404, 409; discussion 409-10, 412-6. PubMed ID: 15828554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The case for routine use of adjuvant therapy in pancreatic cancer.
    Kennedy EP; Yeo CJ
    J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma.
    Artinyan A; Anaya DA; McKenzie S; Ellenhorn JD; Kim J
    Cancer; 2011 May; 117(10):2044-9. PubMed ID: 21523715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASO Visual Abstract: Adjuvant Chemotherapy with or Without Radiotherapy for Resected Pancreatic Cancer Following Multiagent Neoadjuvant Chemotherapy.
    Franklin O; Sugawara T; Ross RB; Franco SR; Colborn K; Karam S; Schulick RD; Chiaro MD
    Ann Surg Oncol; 2024 Aug; 31(8):4997. PubMed ID: 38671290
    [No Abstract]   [Full Text] [Related]  

  • 32. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].
    Seufferlein T; Michalski C
    Chirurg; 2022 May; 93(5):441-445. PubMed ID: 35376964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is there an advantage to neo- or adjuvant chemotherapy in pancreatic cancer?].
    Klapdor R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():135-47. PubMed ID: 1724194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy following resection for pancreatic adenocarcinoma.
    Brennan MF
    Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should further studies of chemotherapy be carried out in pancreatic cancer?
    Taylor I
    Eur J Cancer; 1993; 29A(8):1076-8. PubMed ID: 7686019
    [No Abstract]   [Full Text] [Related]  

  • 37. [Carcinoma of the pancreas: adjuvant and neoadjuvant treatment].
    Enrici RM; Santoro M
    Suppl Tumori; 2002; 1(3):S18-21. PubMed ID: 12415780
    [No Abstract]   [Full Text] [Related]  

  • 38. Pancreatic cancer: a new target for adjuvant therapy and chemotherapy.
    Muggia FM; Megibow A; Douglass HO
    Prog Clin Biol Res; 1985; 201():295-300. PubMed ID: 4095114
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma?
    Pasetto LM; Jirillo A; Stefani M; Monfardini S
    Anticancer Res; 2003; 23(3C):2805-13. PubMed ID: 12926117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possibilities and limits of cytostatic chemotherapy in pancreatic carcinoma].
    Scheithauer W
    Wien Klin Wochenschr; 1994; 106(22):704-8. PubMed ID: 7825320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.